Skip to main content
Premium Trial:

Request an Annual Quote

NIH Seeks Research Proposals for Cancer-Related Protein Biomarker Project

NEW YORK, Feb. 14 (GenomeWeb News) - The National Institutes of Health issued last week a request for research proposals focusing on identifying protein biomarkers for cancer "where etiology of the disease is attributed to infectious agents."


According to the NIH, it is seeking proposals that will help develop resources to identify subpopulations of patients exposed to an infectious agent who are likely to develop infection-associated cancer.


"Identifying these subpopulations has proven difficult," the NIH said. "Molecular markers provide a potential tool to identify the at-risk subpopulation and the presence of early stage cancers. This initiative encourages research to identify proteomic markers for risk assessment and early detection in individuals exposed to infectious agents that have been linked to cancer."


The NIH said that while it will fund select research projects, "because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary." The agency added that no funds have been specifically earmarked for the program, but that "awards pursuant to this funding opportunity are considered of high programmatic significance for funding consideration."


The National Cancer Institute and the National Institute of Dental and Craniofacial Research are the participating institutes on this funding opportunity.


Additional details can be found here.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.